Atom-Level Optical Chemical Structure Recognition with Limited Supervision

Identifying the chemical structure from a graphical representation, or image, of a molecule is a challenging pattern recognition task that would greatly benefit drug development. Yet, existing methods for chemical structure recognition do not typically generalize well, and show diminished effectiveness when confronted with domains where data is sparse, or costly to generate, such as hand-drawn molecule images. To address this limitation, we propose a new chemical structure recognition tool that delivers state-of-the-art performance and can adapt to new domains with a limited number of data samples and supervision. Unlike previous approaches, our method provides atom-level localization, and can therefore segment the image into the different atoms and bonds. Our model is the first model to perform OCSR with atom-level entity detection with only SMILES supervision. Through rigorous and extensive benchmarking, we demonstrate the preeminence of our chemical structure recognition approach in terms of data efficiency, accuracy, and atom-level entity prediction.

Weakly Supervised Knowledge Transfer with Probabilistic Logical Reasoning for Object Detection

Training object detection models usually requires instance-level annotations, such as the positions and labels of all objects present in each image. Such supervision is unfortunately not always available and, more often, only image-level information is provided, also known as weak supervision. Recent works have addressed this limitation by leveraging knowledge from a richly annotated domain. However, the scope of weak supervision supported by these approaches has been very restrictive, preventing them to use all available information. In this work, we propose ProbKT, a framework based on probabilistic logical reasoning that allows to train object detection models with arbitrary types of weak supervision. We empirically show on different datasets that using all available information is beneficial as our ProbKT leads to significant improvement on target domain and better generalization compared to existing baselines. We also showcase the ability of our approach to handle complex logic statements as supervision signal.

Industry-Scale Orchestrated Federated Learning for Drug Discovery

To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n{\deg}831472), which was comprised of 10 pharmaceutical companies, academic research labs, large industrial companies and startups. To the best of our knowledge, The MELLODDY platform was the first industry-scale platform to enable the creation of a global federated model for drug discovery without sharing the confidential data sets of the individual partners. The federated model was trained on the platform by aggregating the gradients of all contributing partners in a cryptographic, secure way following each training iteration. The platform was deployed on an Amazon Web Services (AWS) multi-account architecture running Kubernetes clusters in private subnets. Organisationally, the roles of the different partners were codified as different rights and permissions on the platform and administrated in a decentralized way. The MELLODDY platform generated new scientific discoveries which are described in a companion paper.

SparseChem: Fast and accurate machine learning model for small molecules

SparseChem provides fast and accurate machine learning models for biochemical applications. Especially, the package supports very high-dimensional sparse inputs, e.g., millions of features and millions of compounds. It is possible to train classification, regression and censored regression models, or combination of them from command line. Additionally, the library can be accessed directly from Python. Source code and documentation is freely available under MIT License on GitHub.

Self-Labeling of Fully Mediating Representations by Graph Alignment

To be able to predict a molecular graph structure ($W$) given a 2D image of a chemical compound ($U$) is a challenging problem in machine learning. We are interested to learn $f: U \rightarrow W$ where we have a fully mediating representation $V$ such that $f$ factors into $U \rightarrow V \rightarrow W$. However, observing V requires detailed and expensive labels. We propose graph aligning approach that generates rich or detailed labels given normal labels $W$. In this paper we investigate the scenario of domain adaptation from the source domain where we have access to the expensive labels $V$ to the target domain where only normal labels W are available. Focusing on the problem of predicting chemical compound graphs from 2D images the fully mediating layer is represented using the planar embedding of the chemical graph structure we are predicting. The use of a fully mediating layer implies some assumptions on the mechanism of the underlying process. However if the assumptions are correct it should allow the machine learning model to be more interpretable, generalize better and be more data efficient at training time. The empirical results show that, using only 4000 data points, we obtain up to 4x improvement of performance after domain adaptation to target domain compared to pretrained model only on the source domain. After domain adaptation, the model is even able to detect atom types that were never seen in the original source domain. Finally, on the Maybridge data set the proposed self-labeling approach reached higher performance than the current state of the art.

ChemGrapher: Optical Graph Recognition of Chemical Compounds by Deep Learning

In drug discovery, knowledge of the graph structure of chemical compounds is essential. Many thousands of scientific articles in chemistry and pharmaceutical sciences have investigated chemical compounds, but in cases the details of the structure of these chemical compounds is published only as an images. A tool to analyze these images automatically and convert them into a chemical graph structure would be useful for many applications, such drug discovery. A few such tools are available and they are mostly derived from optical character recognition. However, our evaluation of the performance of those tools reveals that they make often mistakes in detecting the correct bond multiplicity and stereochemical information. In addition, errors sometimes even lead to missing atoms in the resulting graph. In our work, we address these issues by developing a compound recognition method based on machine learning. More specifically, we develop a deep neural network model for optical compound recognition. The deep learning solution presented here consists of a segmentation model, followed by three classification models that predict atom locations, bonds and charges. Furthermore, this model not only predicts the graph structure of the molecule but also produces all information necessary to relate each component of the resulting graph to the source image. This solution is scalable and could rapidly process thousands of images. Finally, we compare empirically the proposed method to a well-established tool and observe significant error reductions.